Literature DB >> 23672886

Biological substrates underpinning diagnosis of major depression.

Etienne Sibille1, Beverly French.   

Abstract

Major depression is characterized by low mood, a reduced ability to experience pleasure and frequent cognitive, physiological and high anxiety symptoms. It is also the leading cause of years lost due to disability worldwide in women and men, reflecting a lifelong trajectory of recurring episodes, increasing severity and progressive treatment resistance. Yet, antidepressant drugs at best treat only one out of every two patients and have not fundamentally changed since their discovery by chance >50 yr ago. This status quo may reflect an exaggerated emphasis on a categorical disease classification that was not intended for biological research and on oversimplified gene-to-disease models for complex illnesses. Indeed, genetic, molecular and cellular findings in major depression suggest shared risk and continuous pathological changes with other brain-related disorders. So, an alternative is that pathological findings in major depression reflect changes in vulnerable brain-related biological modules, each with their own aetiological factors, pathogenic mechanisms and biological/environment moderators. In this model, pathological entities have low specificity for major depression and instead co-occur, combine and interact within individual subjects across disorders, contributing to the expression of biological endophenotypes and potentially clinical symptom dimensions. Here, we discuss current limitations in depression research, review concepts of gene-to-disease biological scales and summarize human post-mortem brain findings related to pyramidal neurons, γ-amino butyric acid neurons, astrocytes and oligodendrocytes, as prototypical brain circuit biological modules. Finally we discuss nested aetiological factors and implications for dimensional pathology. Evidence suggests that a focus on local cell circuits may provide an appropriate integration point and a critical link between underlying molecular mechanisms and neural network dysfunction in major depression.

Entities:  

Mesh:

Year:  2013        PMID: 23672886      PMCID: PMC4074859          DOI: 10.1017/S1461145713000436

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  146 in total

1.  A comparative analysis of the distribution of prosomatostatin-derived peptides in human and monkey neocortex.

Authors:  T L Hayes; J L Cameron; J D Fernstrom; D A Lewis
Journal:  J Comp Neurol       Date:  1991-01-22       Impact factor: 3.215

2.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

3.  Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness.

Authors:  H S Mayberg; M Liotti; S K Brannan; S McGinnis; R K Mahurin; P A Jerabek; J A Silva; J L Tekell; C C Martin; J L Lancaster; P T Fox
Journal:  Am J Psychiatry       Date:  1999-05       Impact factor: 18.112

Review 4.  Somatostatin receptors in brain and pituitary.

Authors:  J Epelbaum; F Agid; Y Agid; A Beaudet; P Bertrand; A Enjalbert; V Heidet; C Kordon; S Krantic; J F Léonard
Journal:  Horm Res       Date:  1989

5.  Altered gene synchrony suggests a combined hormone-mediated dysregulated state in major depression.

Authors:  Chris Gaiteri; Jean-Philippe Guilloux; David A Lewis; Etienne Sibille
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

6.  Limbic-frontal circuitry in major depression: a path modeling metanalysis.

Authors:  D A Seminowicz; H S Mayberg; A R McIntosh; K Goldapple; S Kennedy; Z Segal; S Rafi-Tari
Journal:  Neuroimage       Date:  2004-05       Impact factor: 6.556

Review 7.  Gliogenesis and glial pathology in depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-06       Impact factor: 4.388

8.  Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression.

Authors:  T A Klempan; A Sequeira; L Canetti; A Lalovic; C Ernst; J ffrench-Mullen; G Turecki
Journal:  Mol Psychiatry       Date:  2007-10-16       Impact factor: 15.992

9.  Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: distribution and morphology.

Authors:  F Condé; J S Lund; D M Jacobowitz; K G Baimbridge; D A Lewis
Journal:  J Comp Neurol       Date:  1994-03-01       Impact factor: 3.215

10.  NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.

Authors:  Anita E Autry; Megumi Adachi; Elena Nosyreva; Elisa S Na; Maarten F Los; Peng-fei Cheng; Ege T Kavalali; Lisa M Monteggia
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

View more
  15 in total

Review 1.  Somatostatin-Positive Gamma-Aminobutyric Acid Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives.

Authors:  Corey Fee; Mounira Banasr; Etienne Sibille
Journal:  Biol Psychiatry       Date:  2017-06-08       Impact factor: 13.382

2.  Sustained Molecular Pathology Across Episodes and Remission in Major Depressive Disorder.

Authors:  Enzo Scifo; Mohan Pabba; Fenika Kapadia; Tianzhou Ma; David A Lewis; George C Tseng; Etienne Sibille
Journal:  Biol Psychiatry       Date:  2017-08-18       Impact factor: 13.382

Review 3.  Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders.

Authors:  C Gaiteri; Y Ding; B French; G C Tseng; E Sibille
Journal:  Genes Brain Behav       Date:  2013-12-10       Impact factor: 3.449

4.  Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease.

Authors:  Rowan Saloner; Mariana Cherner; David J Grelotti; Emily W Paolillo; David J Moore; Robert K Heaton; Scott L Letendre; Adarsh Kumar; Igor Grant; Ronald J Ellis
Journal:  Brain Behav Immun       Date:  2020-09-20       Impact factor: 7.217

5.  Persistent Increase in Microglial RAGE Contributes to Chronic Stress-Induced Priming of Depressive-like Behavior.

Authors:  Tina C Franklin; Eric S Wohleb; Yi Zhang; Manoela Fogaça; Brendan Hare; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2017-07-21       Impact factor: 13.382

6.  Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration.

Authors:  M Julia García-Fuster; Jesús A García-Sevilla
Journal:  Psychopharmacology (Berl)       Date:  2016-06-03       Impact factor: 4.530

7.  Depressive residual symptoms are associated with illness course characteristics in a sample of outpatients with bipolar disorder.

Authors:  Gianluca Serafini; Gustavo H Vazquez; Xenia Gonda; Maurizio Pompili; Zoltan Rihmer; Mario Amore
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-02-07       Impact factor: 5.270

Review 8.  Gene-environment interaction in major depression: focus on experience-dependent biological systems.

Authors:  Nicola Lopizzo; Luisella Bocchio Chiavetto; Nadia Cattane; Giona Plazzotta; Frank I Tarazi; Carmine M Pariante; Marco A Riva; Annamaria Cattaneo
Journal:  Front Psychiatry       Date:  2015-05-08       Impact factor: 4.157

9.  Rapid-Acting Antidepressants: Mechanistic Insights and Future Directions.

Authors:  Danielle M Gerhard; Ronald S Duman
Journal:  Curr Behav Neurosci Rep       Date:  2018-02-05

Review 10.  A meta-analysis of lipid peroxidation markers in major depression.

Authors:  Graham Mazereeuw; Nathan Herrmann; Ana C Andreazza; Maisha M Khan; Krista L Lanctôt
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-29       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.